Covaxin’s Phase 3 trials results likely next month
The results of third phase trials of India's first indigenously developed Covid-19 vaccine Covaxin are expected to be released next month. ovaxin manufacturer Bharat Biotech said its service provider, IQVIA, has started final statistical…